Search - tctmd.com

Displaying 201 - 220 of 222

Sort: Relevancy | Date

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Caitlin E. Cox

August 16, 2012

News Daily News

Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año

L.A. McKeown

July 30, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

Presentation TCT 2012

Healing Responses After Bifurcation Stenting with the Dedicated TRYTON Side-Branch Stent in Combination with XIENCE V Stents: an Angiography and Optical Coherence Tomography Study.

Presenter: Christophe L. Dubois, Tom Adriaenssens, Giovanni Ughi, Mark Coosemans, Bert Ferdinande, Peter Sinnaeve, Walter Desmet

January 03, 2012

News Daily News

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

September 19, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Daily News

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

L.A. McKeown

August 19, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

May 16, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Daily News

Women Less Likely to Receive Evidence-Based Therapies Than Men

Jason Kahn

March 09, 2011

News Daily News

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

L.A. McKeown

February 28, 2011

Advertisement

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

SCAAR: Second-Generation DES Improve Hard Outcomes

Healing Responses After Bifurcation Stenting with the Dedicated TRYTON Side-Branch Stent in Combination with XIENCE V Stents: an Angiography and Optical Coherence Tomography Study.

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

New-Generation DES Reduce Restenosis, Stent Thrombosis

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Women Have Less Neointimal Hyperplasia Than Men With ZES

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Women Less Likely to Receive Evidence-Based Therapies Than Men

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content